The metrics that have defined elite human performance for the past decade are quietly becoming baseline commodities. The global vanguard has spent years meticulously quantifying the vessel—mapping heart rate variability like financial charts, tracking sleep architecture, and measuring glycemic responses to environmental inputs. Yet, as the physical domain becomes increasingly optimized, a profound realization is taking root among those who operate at the absolute limits of pe

Stéphane Molère is the founder and president of Private Equity Valley, a private investment and wealth structuring platform within the Éthique & Patrimoine group. Longevity is not about living longer—it is about protecting judgment, capital, and legacy over time. Stéphane Molère explains why. To Win Long Term, First Avoid Losing On Longevity, Risk, and Capital.

Imagine arriving at your office on a Monday morning, your schedule packed with high-stakes meetings, strategic decisions, and back-to-back travel. Yet, despite your accomplishments, something feels off: your energy dips, your focus wavers, and recovery from late nights seems slower than it used to be. For executives and high-performing leaders, these subtle declines are more than inconvenience—they are signals from your cells. Enter NAD+ (Nicotinamide Adenine Dinucleotide),

In today’s world, longevity is no longer measured merely by years or physical health. Brainspan equips leaders with mental clarity, cognitive agility, and sharp focus, the foundation of enduring executive influence. But insight alone is potential — it must be translated into sustained, high-impact action. This is Performancespan: the art of leading with mastery, decisiveness, and influence across decades. It is where strategy meets execution, clarity becomes action, and visi